We developed an improved enzymatic assay of D-sorbitol in human erythrocytes by employing highly speci®c D-sorbitol dehydrogenase from Pseudomonas sp. (EC 1.1.1.14) and replacing perchloric acid (HClO 4 ) and potassium carbonate (K 2 CO 3 ), generally used for deproteinization, with sodium hydroxide (NaOH) and zinc sulphate (ZnSO 4 ). In this assay, erythrocytes were separated from plasma by centrifugation and washed once with physiological saline. Subsequently, the erythrocytes were lysed with distilled water and proteins precipitated with NaOH and ZnSO 4 . After centrifugation, the resulting colourless supernatant was mixed with a glycine buffer (pH 9´0) containing NAD + and D-sorbitol dehydrogenase. After incubation for 30 min at 37°C, the NADH produced was measured uorimetrically. The¯uorescence intensities were corrected for sample blanks, and the values of D-sorbitol were normalized for haemoglobin content.
INTRODUCTION
In patients with diabetes, elevated levels of Dsorbitol have been detected in both the lens and peripheral nervous tissues. 1 Animal and clinical studies suggest that D-sorbitol accumulation results from activation of the polyol pathway, which consists of two enzymes, aldose reductase (EC 1.1.1.21) and D-sorbitol dehydrogenase (EC 1.1. 1.14) . 2±6 This pathway has been suspected of participating in the pathogenesis of diabetesassociated complications. 7±9 Because human erythrocytes have the capacity to generate D-sorbitol via the polyol pathway, the D-sorbitol level is useful as an indicator of diabetic control. 10±13 Many different analytical methods, such as gas±liquid chromatography, 6, 14 liquid chromatography 3, 15 and enzymatic methods with¯uorometric detection, 2, 16, 17 have been reported for quantifying D-sorbitol in erythrocytes. Among these, gas±liquid chromatography and liquid chromatography are not suitable for clinical use to assay a large number of samples. On the other hand, enzymatic methods with¯uorometric detection are suitable for assaying a large number of samples, but require complicated and time-consuming pretreatment of samples, including the precipitation of proteins. 2, 17 Furthermore, samples deproteinized with HClO 4 are prone to spectral interference, which affects thē uorescence measurement, and the use of HClO 4 requires neutralization with K 2 CO 3 to prevent the inactivation of D-sorbitol dehydrogenase by the acid.
To overcome these problems, we attempted to improve the enzymatic method with¯uorometric detection by modifying the enzyme and deproteinizing reagents. Using the improved method, we analysed blood samples from 50 normal fasting subjects and 112 diabetic subjects, and succeeded in establishing a baseline value for D-sorbitol in clinical studies.
PRINCIPLE
Oxidation of D-sorbitol to fructose is catalysed by D-sorbitol dehydrogenase in the presence of NAD + , resulting in the formation of NADH. The amount of D-sorbitol was determined by measuring the¯uorescence derived from the NADH formed.
MATERIALS AND METHODS

Chemicals
D-Sorbitol dehydrogenase (EC 1.1.1.14) 18 and NAD + (b-nicotinamide adenine dinucleotide) were purchased from Kikkoman Corporation (Noda, Japan) and Oriental Yeast Co. (Tokyo, Japan), respectively. D-Sorbitol and other chemicals (reagent grade) were obtained from Wako Pure Chemicals Industries Ltd (Osaka, Japan).
Instrument
We used a model F-4010¯uorescence spectrophotometer (Hitachi Ltd, Tokyo, Japan) with excitation and emission wavelengths of 366 and 452 nm, respectively, and a 10-nm bandpass. Time averaging was 5 s (the average value of measured signal for 5 s was calculated) and response time (the time needed to improve the signal-to-noise ratio with the computer) was 2 s.
Sample preparation
Venous blood (5 mL), collected in glass tubes containing 10´5 mg of disodium EDTA, was immediately centrifuged for 15 min. After removing the plasma and buffy coat, erythrocytes were washed with physiological saline and centrifuged again for 15 min. The erythrocyte pellet was either assayed immediately, or stored at 2 80°C until use. The stored samples were stable for at least 6 months. When stored samples were used, they were allowed to stand at room temperature until thawed, and then assayed immediately.
Standards
The stock standard solution was prepared by dissolving D-sorbitol in physiological saline to give a concentration of 0´1 mol/L, and stored at 6±10°C. A series of working standards (0, 20, 40 and 80 mmol/L) was prepared by diluting the stock solution appropriately with physiological saline before use.
Assay procedure
Distilled water, 5 mL, was added to 1 mL of erythrocytes and the mixture shaken vigorously for 10 s to lyse the cells. After that, 1 mL of ZnSO 4 solution (0´3 mol/L) and 1 mL of NaOH solution (0´475 mol/L) were added to the cell lysate to precipitate the protein. The supernatant, separated by a 10-min centrifugation at 2000 g, was used as a sample for the assay. The working standards were similarly treated, and used for the assay.
As an alternative method for comparison, 3´0 mL of 4% HClO 4 solution was added to 1´0 mL of erythrocytes and the mixture centrifuged at 2000 g for 10 min. The supernatant was neutralized with 2´5 mol/L K 2 CO 3 and then allowed to stand for 2 h at 4°C. the resulting supernatant was used as a sample for the assay.
Two millilitres of the supernatant was transferred to a glass tube and incubated with 1 mL of 0´15 mol/L glycine±NaOH buffer (pH 9´0) containing D-sorbitol dehydrogenase (2 kU/L), 0´003 mol/L NAD + and 0´01 mol/L disodium EDTA at 37°C. After incubation for 30 min, thē uorescence emitted from the NADH formed was measured at room temperature within 1 h. For the sample blank or working standard blank, a second 2-mL aliquot of the supernatant was assayed in the same manner, except for the omission of D-sorbitol dehydrogenase.
Quanti®cation of D-sorbitol
A standard curve was prepared by plotting the net¯uorescence intensities, obtained by subtracting the working standard blank from those of enzymatic reaction, against D-sorbitol concentrations. D-Sorbitol concentrations in erythrocyte samples were read from this standard curve.
Haemoglobin concentration in the sample
The haemoglobin concentration in blood sample aliquots was measured using a Hemoglobin-Test Wako kit (Wako Pure Chemicals Industries Ltd, Osaka, Japan) which was based on the measurement of cyanmethaemoglobin. 19 D-Sorbitol concentrations were expressed as mmol/g of haemoglobin.
RESULTS
Effect of pretreatment of samples on the sensitivity of assay
In order to improve complicated pretreatments of samples and to remove interfering factors affecting the assay, we used pretreatment with NaOH and ZnSO 4 20 instead of conventional HClO 4 and K 2 CO 3 . After haemolysis of erythrocytes with distilled water, ZnSO 4 and NaOH solutions were added to the cell lysate and proteins were precipitated. After centrifugation the supernatant was colourless and no quenching of¯uorescence was observed. The interference with the activity of D-sorbitol dehydrogenase by zinc ions contained in the supernatant was avoided by the addition of > 0´0075 mol/L disodium EDTA (data not shown).
We compared our method of sample pretreatment with that using HClO 4 and K 2 CO 3 . Erythrocyte samples supplemented with Dsorbitol in the range 0±180 mmol/L were prepared, and each sample was assayed in ®ve replicates after pretreatment with the two methods, as described in Materials and Methods. As shown in Fig. 1 , the intensity of uorescence obtained by our method was about twice that obtained using HClO 4 and K 2 CO 3 (the¯uorescence was corrected for the difference in sample dilutions between the two pretreatments).
Optimum pH of the assay
The optimum pH of the assay was examined using three kinds of buffer (0´15 mol/L Na phosphate buffer, 0´15 mol/L Tris±HCl buffer, and 0´15 mol/L glycine±NaOH buffer) in the range of pH 6´0±10´5. D-Sorbitol solution (30 mmol/L), diluted with physiological saline, was assayed according to the standard procedure. Using glycine buffer in the pH range 9´0± 10´0, a maximum¯uorescence intensity was obtained (Fig. 2 ). The stability of reagents, particularly NAD + , was also examined, and the result indicated that there was no elevation of background¯uorescence at pH 9´0 for 3 days; 0´15 mol/L glycine buffer (pH 9´0) was therefore used as a reaction buffer.
Calibration curve
When¯uorescence intensities were plotted against D-sorbitol concentrations, the resulting calibration curve showed a linearity up to 180 mmol/L within 5% of deviations from theoretical values (Fig. 3) . In our assay system the¯uorescence intensity was measured after reaching a plateau, so that a precise timing for measurements after incubation was unnecessary.
Precision studies
The intra-assay precision was assessed by using 20 replicate analyses of three samples of approximately 22, 59 and 85 mmol/L. As shown in Table 1 , coef®cients of variation (CVs) of the method with NaOH and ZnSO 4 were in the range 0´5±3´3%, whereas CVs of the method with HClO 4 and K 2 CO 3 were in the range 3´7± 14%. The inter-assay precision was assessed by analysing samples in the same manner on 7 consecutive days, and the CVs of the two methods, NaOH/ZnSO 4 and HClO 4 /K 2 CO 3 were in the range of 1´6±5´8% and 7´5±22%, respectively (Table 1) . Furthermore, we assayed three different samples of approximately 22, 59 and 85 mmol/L with three separately prepared batches of our reagents with NaOH and ZnSO 4 , and the CVs of the results were in the range 2´9±3´2% (Table 1 ). These results indicated that our assay system with NaOH and ZnSO 4 is accurate, and the results are reproducible.
Linearity
The linearity of the assay was evaluated using serial dilutions of two different samples (75 and 105 mmol/L). The results of the linearity study obtained by the methods of NaOH and ZnSO 4 are indicated in Fig. 4 . Within the measuring range the deviations from theoretical values did not exceed 5%, indicating no lack of parallelism.
On the other hand, the results obtained by the method of HClO 4 and K 2 CO 3 lacked parallelism (data not shown).
Recovery
Recovery was assessed by spiking three different samples with low, medium and high D-sorbitol concentrations in the 20±40 mmol/L range. The percentage recovery of D-sorbitol at each concentration ranged from 91´3 to 103´6% (mean 98´6%) in the assay with NaOH and ZnSO 4 , and from 82´1 to 93´5% (mean 88´2%) in the assay with HClO 4 and K 2 CO 3 .
Lower limit of detection
Physiological saline was measured in 20 replicates and the standard deviation (SD) of measurement values calculated. The lower limit of detection, as de®ned by the mean+3 SD, was the same value of 0´65 mmol/L for both assays with NaOH/ZnSO 4 and HClO 4 /K 2 CO 3 .
Interference
We examined the effects of free bilirubin, ditaurobilirubin, intrafat and ascorbic acid on D-sorbitol measurement by using three different samples (approximately 22, 59 and 85 mmol/L). The results showed that free bilirubin and ditaurobilirubin, up to 428 and 300 mmol/L, respectively, did not affect the assay with NaOH and ZnSO 4 . Similarly, intrafat up to 50 g/L, and ascorbic acid up to 300 mg/L, did not affect the assay with NaOH and ZnSO 4 . On the other hand, free bilirubin and ditaurobilirubin, at > 171 and 112 mmol/L, respectively, and intrafat at > 25 g/L, affected the assay with HClO 4 and K 2 CO 3 . We also examined the effect of popular anticoagulants (NaF, EDTA, heparin and oxalate) at the concentrations generally used. None of them affected the assay with NaOH and ZnSO 4 nor the assay with HClO 4 and K 2 CO 3 .
We examined the speci®city of our assay system by using various polyols and sugars (xylitol, mannitol, arabitol, sucrose, fructose, sorbose, xylose, galactose, mannose and glucose) in comparison with D-sorbitol at a concentration of 50 mmol/L. The¯uorescence response of both polyol and sugar was < 2% relative to Dsorbitol, suggesting no signi®cant interference of the assay by polyols and sugars.
Clinical baseline (cut-off value)
To establish a clinical baseline value in our assay system, we analysed blood samples from 50 normal fasting subjects and 112 diabetic subjects for D-sorbitol and haemoglobin. We obtained a mean D-sorbitol/haemoglobin ratio of 27´4 (SD 7´2) nmol/g for normal fasting subjects, and 57´3 (SD 23´0) nmol/g for diabetic subjects. Furthermore, the result of receiver±operating characteristic (ROC) analysis showed that, in the range of clinical baseline values from 40 to 43 nmol/g diagnostic speci®city remained at 0´98, whereas diagnostic sensitivity decreased from 0´74 to 0´70 (Table 2) . We therefore de®ned 40 nmol/g as a clinical cut-off value. This value agreed well with that of the mean+2 SD (41´8 nmol/g) obtained from normal fasting subjects.
DISCUSSION
D-Sorbitol, an intermediate in the polyol pathway, is known to accumulate in some tissues in the presence of sustained hyperglycaemia, as in diabetic patients. 1, 6, 15 Recent ®ndings show that the D-sorbitol concentration in erythrocytes is signi®cantly elevated in diabetic subjects compared to normals, 2 suggesting that its value could be an important indicator of tissue Dsorbitol levels. 10±13 On the other hand, analytical methods so far available for the quanti®cation of D-sorbitol in erythrocytes are not suitable for assaying a large number of samples in clinical studies. 3, 6, 14, 15 We therefore attempted to modify an enzymatic¯uorometric assay.
Although D-sorbitol dehydrogenase derived from sheep liver is commonly used for the determination of D-sorbitol, this enzyme is not strictly speci®c for D-sorbitol and it is dif®cult to ascertain the amount of D-sorbitol accurately when other sugars, such as xylitol, are contained in the sample. 17 In our experiment we used Dsorbitol dehydrogenase derived from Pseudomonas sp., which was purchased from Kikkoman Corporation. This enzyme was stable from pH 5´5 to 10´5, and showed strict substrate speci®city at pH 9´0. 18 Furthermore, we modi®ed the method of deproteinization by using NaOH and ZnSO 4 , as shown by Shinohara et al. 20 In our assay system we speeded the sample preparation by washing once with physiological saline and performed cell lysis with distilled water. In addition, we facilitated the step of deproteinization by using NaOH and ZnSO 4 instead of HClO 4 and K 2 CO 3 . 2, 17 This change in sample pretreatment enabled us to obtain a colourless supernatant, and not the pale yellow± brown one obtained after deproteinization with HClO 4 , and to omit the 2 h cooling for neutralization and precipitation of HClO 4 with K 2 CO 3 . As a result, our assay system showed better accuracy, precision and sensitivity than that with HClO 4 and K 2 CO 3 .
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that obtained by the assay of D-sorbitol in erythrocytes. As shown in Fig. 5 , we found a positive correlation between the two (y=2 12´17+1´81x, r=0´81), indicating that whole blood might be used in our method. The sensitivity of the assay of whole blood was about the same as that of erythrocytes (data not shown). In this case it is essential to collect blood under strict fasting conditions, because Dsorbitol is a food additive and may affect Dsorbitol values in whole blood.
There are several reports of clinical cut-off values for D-sorbitol in diabetic patients, obtained by enzymatic and¯uorometric methods. 10,21±23 Malone et al. 10, 21 reported that D-sorbitol concentrations in erythrocytes were 10´16 7´2 in normal children, and 10´36 0´8 nmol/g in normal youths. On the other hand, Ishida et al. 22 and Aida et al. 23 reported that D-sorbitol concentrations in erythrocytes were 52´96 12´1 in normal subjects (aged from 8 to 74 years), and 31´76 1´0 nmol/g in normal adults. They used Dsorbitol dehydrogenase derived from sheep liver and deproteinized the samples with HClO 4 and K 2 CO 3 . The discrepancy in values may be due to differences in the assay systems, particularly enzyme speci®city and the ef®ciency of deproteinization.
In conclusion, this improved procedure is accurate, precise and sensitive for assaying Dsorbitol in human erythrocytes. The method of sample pretreatment and the assay conditions are designed to minimize tedious manipulations and save time. Furthermore, the enzymatic reaction reached a plateau in 25 min and the¯uorescence intensity was stable for longer than 1 h. We hope that this method will prove to be a practical and useful technique in clinical medicine. Using this method, further studies in diabetic patients with complications are in progress in order to clarify the relationship between the complications and D-sorbitol values.
